Kari Ylitalo
Overview
Explore the profile of Kari Ylitalo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
518
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muroke V, Jalanko M, Haukka J, Patila T, Hartikainen J, Tahvanainen A, et al.
Scand Cardiovasc J
. 2023 Jun;
57(1):2215490.
PMID: 37264780
. It has been unclear whether simple atrial septal defect (ASD) is an independent risk factor for infective endocarditis (IE). This study aimed to untangle the risk of endocarditis in...
2.
Makikallio T, Junttila J, Kiviniemi A, Kurl S, Ylitalo K, Magga J, et al.
Int J Cardiol
. 2016 Oct;
225:47-49.
PMID: 27710802
No abstract available.
3.
Alestalo K, Korpi R, Makela J, Lehtonen S, Makela T, Yannopoulos F, et al.
Scand Cardiovasc J
. 2015 Feb;
49(2):82-94.
PMID: 25705991
Objective: The clinical data considering the bone marrow mononuclear cell (BMMNC) therapy in treatment for acute myocardial infarction (AMI) are controversial and the mechanisms remain unknown. Our objective was to...
4.
Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, Ylitalo K, et al.
Circulation
. 2014 Dec;
131(7):624-32.
PMID: 25527698
Background: This study was designed to assess the epidemiology, characteristics, and outcome of cardiac sarcoidosis (CS) in Finland. Methods And Results: We identified in retrospect all adult (>18 years of...
5.
Alestalo K, Lehtonen S, Yannopoulos F, Makela T, Makela J, Ylitalo K, et al.
Tissue Eng Part A
. 2012 Dec;
19(9-10):1122-31.
PMID: 23216049
Stem cell therapy represents a potential novel additional therapy for acute myocardial infarction. Cardiac applications of stem cell therapy are now undergoing clinical trials though many properties, including localization, possible...
6.
Napankangas J, Liimatta E, Joensuu P, Bergmann U, Ylitalo K, Hassinen I
J Mol Cell Cardiol
. 2012 Oct;
53(6):906-15.
PMID: 23036824
Reactive oxygen species (ROS) have been implicated in many aspects of tissue/cellular metabolic signaling and pathology, including cardioprotection against ischemia-reperfusion damage. Recent reports of enhanced ROS production under global or...
7.
Lehtonen S, Makela J, Ohlmeier S, Ylitalo K, Juvonen T, Anttila V, et al.
J Tissue Eng Regen Med
. 2012 May;
8(2):97-105.
PMID: 22552865
Although several studies have demonstrated a functional recovery of infarcted myocardial tissue after cell therapy, little is known about the molecular mechanisms behind it. The aim of this study was...
8.
Miettinen J, Salonen R, Ylitalo K, Niemela M, Kervinen K, Saily M, et al.
J Transl Med
. 2012 Apr;
10:66.
PMID: 22462635
Background: Treatment of acute myocardial infarction with stem cell transplantation has achieved beneficial effects in many clinical trials. The bone marrow microenvironment of ST-elevation myocardial infarction (STEMI) patients has never...
9.
Maki M, Koskenvuo J, Ukkonen H, Saraste A, Tuunanen H, Pietila M, et al.
Front Physiol
. 2012 Feb;
3:6.
PMID: 22363288
Purpose: Beneficial mechanisms of bone marrow cell (BMC) therapy for acute ST-segment elevation myocardial infarct (STEMI) are largely unknown in humans. Therefore, we evaluated the feasibility of serial positron emission...
10.
Makela J, Yannopoulos F, Ylitalo K, Makikallio T, Lehtonen S, Lappi-Blanco E, et al.
Cardiovasc Pathol
. 2011 Aug;
21(3):132-42.
PMID: 21839651
Background: Bone marrow-derived mononuclear cell (BMMC) treatment in acute myocardial infarction (AMI) has been shown to have a beneficial effect. Our objective was to study in detail the histopathological process...